Acer therapeutics and relief therapeutics announce update on u.s. fda review of new drug application (nda) for acer-001

Citing the need to inspect a third-party contract packaging manufacturer, the u.s. food and drug administration (fda) has issued a complete response letter (crl)
ACER Ratings Summary
ACER Quant Ranking